These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31245962)

  • 1. Cannabis involvement and neuropsychological performance: findings from the Human Connectome Project.
    Petker T; Owens MM; Amlung MT; Oshri A; Sweet LH; MacKillop J
    J Psychiatry Neurosci; 2019 Nov; 44(6):414-422. PubMed ID: 31245962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal changes in cognition in young adult cannabis users.
    Becker MP; Collins PF; Schultz A; Urošević S; Schmaling B; Luciana M
    J Clin Exp Neuropsychol; 2018 Aug; 40(6):529-543. PubMed ID: 29058519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological performance in young adults with cannabis use disorder.
    Selamoglu A; Langley C; Crean R; Savulich G; Cormack F; Sahakian BJ; Mason B
    J Psychopharmacol; 2021 Nov; 35(11):1349-1355. PubMed ID: 34694178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary tetrahydrocannabinol is associated with poorer working memory performance and alterations in associated brain activity.
    Owens MM; McNally S; Petker T; Amlung MT; Balodis IM; Sweet LH; MacKillop J
    Neuropsychopharmacology; 2019 Feb; 44(3):613-619. PubMed ID: 30644440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily, but not occasional, cannabis use is selectively associated with more impulsive delay discounting and hyperactive ADHD symptoms in binge-drinking young adults.
    Petker T; Ferro M; Van Ameringen M; Murphy J; MacKillop J
    Psychopharmacology (Berl); 2021 Jul; 238(7):1753-1763. PubMed ID: 33638699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings.
    Sánchez-Torres AM; Basterra V; Rosa A; Fañanás L; Zarzuela A; Ibáñez B; Peralta V; Cuesta MJ
    Eur Arch Psychiatry Clin Neurosci; 2013 Dec; 263(8):643-53. PubMed ID: 23580110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationship to symptoms of cannabis use disorders.
    Gonzalez R; Schuster RM; Mermelstein RJ; Vassileva J; Martin EM; Diviak KR
    J Clin Exp Neuropsychol; 2012; 34(9):962-76. PubMed ID: 22882144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing cognitive functioning in individuals with cocaine use disorder.
    Frazer KM; Manly JJ; Downey G; Hart CL
    J Clin Exp Neuropsychol; 2018 Aug; 40(6):619-632. PubMed ID: 29226762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure.
    D'Souza DC; Ganesh S; Cortes-Briones J; Campbell MH; Emmanuel MK
    Psychol Med; 2020 Oct; 50(14):2452-2459. PubMed ID: 31615592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ADHD and cannabis use on executive functioning in young adults.
    Tamm L; Epstein JN; Lisdahl KM; Molina B; Tapert S; Hinshaw SP; Arnold LE; Velanova K; Abikoff H; Swanson JM;
    Drug Alcohol Depend; 2013 Dec; 133(2):607-14. PubMed ID: 23992650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of decision-making in cannabis-related problems among young adults.
    Gonzalez R; Schuster RM; Mermelstein RM; Diviak KR
    Drug Alcohol Depend; 2015 Sep; 154():214-21. PubMed ID: 26199058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct effects of cocaine and cocaine + cannabis on neurocognitive functioning and abstinence: A six-month follow-up study.
    Oliveira HP; Gonçalves PD; Ometto M; Santos BD; Malbergier A; Amaral R; Nicastri S; Andrade AG; Cunha PJ
    Drug Alcohol Depend; 2019 Dec; 205():107642. PubMed ID: 31683245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerobic Fitness Level Moderates the Association Between Cannabis Use and Executive Functioning and Psychomotor Speed Following Abstinence in Adolescents and Young Adults.
    Wade NE; Wallace AL; Swartz AM; Lisdahl KM
    J Int Neuropsychol Soc; 2019 Feb; 25(2):134-145. PubMed ID: 30474579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Psychopharmacology (Berl); 2016 Mar; 233(5):809-21. PubMed ID: 26621349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
    Ringen PA; Vaskinn A; Sundet K; Engh JA; Jónsdóttir H; Simonsen C; Friis S; Opjordsmoen S; Melle I; Andreassen OA
    Psychol Med; 2010 Aug; 40(8):1337-47. PubMed ID: 19891810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder.
    Ringen PA; Melle I; Berg AO; Agartz I; Spigset O; Simonsen C; Sundet K; Andreassen OA
    Schizophr Res; 2013 Jan; 143(1):84-9. PubMed ID: 23178107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review.
    Broyd SJ; van Hell HH; Beale C; Yücel M; Solowij N
    Biol Psychiatry; 2016 Apr; 79(7):557-67. PubMed ID: 26858214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.